Category: Intellectual property
-
Evotec Acquiring Sanofi Infectious Disease Portfolio
Drug discovery company Evotec AG is licensing 10 infectious disease R&D programs and their 100 employees from drug maker Sanofi, and opening new labs for this work in Lyon, France.
-
Company Formed to Develop Cancer Cell Therapies
The MD Anderson Cancer Center in Houston is starting Optera Therapeutics Corp., a new company to commercialize its research on treating cancer with a patients’ own immune system cells.
-
Start-Up Developing Blood-Brain Barrier Treatments
A medical school professor in Singapore is starting a biotechnology company to discover and develop new drugs for neurological disorders based on his research with mechanisms for crossing the blood-brain barrier.
-
Pharma, Biotech Partner on Neuro Therapies in $1.1B Deal
Voyager Therapeutics, a developer of gene therapies for neurological disorders, is collaborating with drug maker AbbVie on treatments for diseases resulting from the build-up of damaging proteins in the brain, as in Alzheimer’s disease.
-
Patents Awarded for Genetic Editing of CAR T-Cells
U.S. patents were awarded to a biotechnology company developing therapies using the genomic editing process known as Crispr to create immune system cells with proteins for attacking cancer cells.
-
Securing Your Small Business’s Profit
Unfortunately, if you don’t take the right steps, others will be able to directly copy your work and profit from it and there won’t be a whole lot that you can do.
-
Biotechs Collaborate on Immunotherapies in $1.2B Deal
Two biotechnology companies developing cancer therapies harnessing the immune system are partnering on new treatments for solid tumor and blood-related cancers.
-
Neuro Therapy Company Spins-Off, Gains $20.8M Funding
A company developing treatments for cognitive impairment and Alzheimer’s disease is starting-up in Belgium, with a technology and financial backing from local and global businesses and investors.
-
Biotech, Univ. Lab Partner on Stem Cells for Alzheimer’s
A biotechnology company specializing in stem cell therapeutics is licensing a process from Texas A&M University to produce exosomes — cellular delivery packages — from adult stem cells as possible therapies for Alzheimer’s disease.
-
Biotech, Pharma Dominate U.S. Academic Patents
In 2016, patents on biotechnology, pharmaceuticals, and medical technologies accounted for 40 percent of all academic patents, with measurement technologies and organic chemistry each getting 7 percent of the total.